189 related articles for article (PubMed ID: 22322921)
1. Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention.
Costa B; Barrio F; Cabré JJ; Piñol JL; Cos X; Solé C; Bolíbar B; Basora J; Castell C; Solà-Morales O; Salas-Salvadó J; Lindström J; Tuomilehto J;
Diabetologia; 2012 May; 55(5):1319-28. PubMed ID: 22322921
[TBL] [Abstract][Full Text] [Related]
2. Lifestyle interventions for diabetes mellitus type 2 prevention.
Sagarra R; Costa B; Cabré JJ; Solà-Morales O; Barrio F;
Rev Clin Esp (Barc); 2014 Mar; 214(2):59-68. PubMed ID: 24267869
[TBL] [Abstract][Full Text] [Related]
3. Rationale and design of the PREDICE project: cost-effectiveness of type 2 diabetes prevention among high-risk Spanish individuals following lifestyle intervention in real-life primary care setting.
Costa B; Cabré JJ; Sagarra R; Solà-Morales O; Barrio F; Piñol JL; Cos X; Bolíbar B; Castell C; Kissimova-Skarbek K; Tuomilehto J;
BMC Public Health; 2011 Aug; 11():623. PubMed ID: 21831332
[TBL] [Abstract][Full Text] [Related]
4. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
[TBL] [Abstract][Full Text] [Related]
5. Implementation of the DP-TRANSFERS project in Catalonia: A translational method to improve diabetes screening and prevention in primary care.
Costa-Pinel B; Mestre-Miravet S; Barrio-Torrell F; Cabré-Vila JJ; Cos-Claramunt X; Aguilar-Sanz S; Solé-Brichs C; Castell-Abat C; Arija-Val V; Lindström J;
PLoS One; 2018; 13(3):e0194005. PubMed ID: 29543842
[TBL] [Abstract][Full Text] [Related]
6. Effective translation of a type-2 diabetes primary prevention programme into routine primary care: The PreDE cluster randomised clinical trial.
Sanchez A; Silvestre C; Campo N; Grandes G;
Diabetes Res Clin Pract; 2018 May; 139():32-42. PubMed ID: 29476888
[TBL] [Abstract][Full Text] [Related]
7. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
[TBL] [Abstract][Full Text] [Related]
8. Determinants of weight outcomes in type 2 diabetes prevention intervention in primary health care setting (the DE-PLAN project).
Gilis-Januszewska A; Piwońska-Solska B; Lindström J; Wójtowicz E; Tuomilehto J; Schwarz PEH; Kissimova-Skarbek K; Szybiński Z; Windak A; Hubalewska-Dydejczyk A
BMC Public Health; 2018 Jan; 18(1):97. PubMed ID: 29291708
[TBL] [Abstract][Full Text] [Related]
9. Digitally supported program for type 2 diabetes risk identification and risk reduction in real-world setting: protocol for the StopDia model and randomized controlled trial.
Pihlajamäki J; Männikkö R; Tilles-Tirkkonen T; Karhunen L; Kolehmainen M; Schwab U; Lintu N; Paananen J; Järvenpää R; Harjumaa M; Martikainen J; Kohl J; Poutanen K; Ermes M; Absetz P; Lindström J; Lakka TA;
BMC Public Health; 2019 Mar; 19(1):255. PubMed ID: 30823909
[TBL] [Abstract][Full Text] [Related]
10. Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial.
Taheri S; Zaghloul H; Chagoury O; Elhadad S; Ahmed SH; El Khatib N; Amona RA; El Nahas K; Suleiman N; Alnaama A; Al-Hamaq A; Charlson M; Wells MT; Al-Abdulla S; Abou-Samra AB
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):477-489. PubMed ID: 32445735
[TBL] [Abstract][Full Text] [Related]
11. Rationale and design of the DP-TRANSFERS project: diabetes prevention-transferring findings from European research to society in Catalonia.
Costa B; Castell C; Cos X; Solé C; Mestre S; Canela M; Boquet A; Cabré JJ; Barrio F; Flores-Mateo G; Ferrer-Vidal D; Lindström J;
J Transl Med; 2016 Apr; 14(1):103. PubMed ID: 27118544
[TBL] [Abstract][Full Text] [Related]
12. Behavioural interventions to promote physical activity in a multiethnic population at high risk of diabetes: PROPELS three-arm RCT.
Khunti K; Griffin S; Brennan A; Dallosso H; Davies M; Eborall H; Edwardson C; Gray L; Hardeman W; Heathcote L; Henson J; Morton K; Pollard D; Sharp S; Sutton S; Troughton J; Yates T
Health Technol Assess; 2021 Dec; 25(77):1-190. PubMed ID: 34995176
[TBL] [Abstract][Full Text] [Related]
13. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.
; Knowler WC; Fowler SE; Hamman RF; Christophi CA; Hoffman HJ; Brenneman AT; Brown-Friday JO; Goldberg R; Venditti E; Nathan DM
Lancet; 2009 Nov; 374(9702):1677-86. PubMed ID: 19878986
[TBL] [Abstract][Full Text] [Related]
14. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project.
Laatikainen T; Dunbar JA; Chapman A; Kilkkinen A; Vartiainen E; Heistaro S; Philpot B; Absetz P; Bunker S; O'Neil A; Reddy P; Best JD; Janus ED
BMC Public Health; 2007 Sep; 7():249. PubMed ID: 17877832
[TBL] [Abstract][Full Text] [Related]
15. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial.
Wittert G; Bracken K; Robledo KP; Grossmann M; Yeap BB; Handelsman DJ; Stuckey B; Conway A; Inder W; McLachlan R; Allan C; Jesudason D; Fui MNT; Hague W; Jenkins A; Daniel M; Gebski V; Keech A
Lancet Diabetes Endocrinol; 2021 Jan; 9(1):32-45. PubMed ID: 33338415
[TBL] [Abstract][Full Text] [Related]
16. Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT.
Penn L; White M; Lindström J; den Boer AT; Blaak E; Eriksson JG; Feskens E; Ilanne-Parikka P; Keinänen-Kiukaanniemi SM; Walker M; Mathers JC; Uusitupa M; Tuomilehto J
PLoS One; 2013; 8(2):e57143. PubMed ID: 23451166
[TBL] [Abstract][Full Text] [Related]
17. Feasibility and effectiveness of the implementation of a primary prevention programme for type 2 diabetes in routine primary care practice: a phase IV cluster randomised clinical trial.
Sanchez A; Silvestre C; Sauto R; Martínez C; Grandes G;
BMC Fam Pract; 2012 Nov; 13():109. PubMed ID: 23158830
[TBL] [Abstract][Full Text] [Related]
18. Effects of dietary and physical activity interventions on the risk of type 2 diabetes in South Asians: meta-analysis of individual participant data from randomised controlled trials.
Jenum AK; Brekke I; Mdala I; Muilwijk M; Ramachandran A; Kjøllesdal M; Andersen E; Richardsen KR; Douglas A; Cezard G; Sheikh A; Celis-Morales CA; Gill JMR; Sattar N; Bhopal RS; Beune E; Stronks K; Vandvik PO; van Valkengoed IGM
Diabetologia; 2019 Aug; 62(8):1337-1348. PubMed ID: 31201437
[TBL] [Abstract][Full Text] [Related]
19. Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery.
Vermunt PW; Milder IE; Wielaard F; Baan CA; Schelfhout JD; Westert GP; van Oers HA
BMC Fam Pract; 2012 Aug; 13():79. PubMed ID: 22873753
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
